Search

Your search keyword '"Kimby, Eva"' showing total 923 results

Search Constraints

Start Over You searched for: Author "Kimby, Eva" Remove constraint Author: "Kimby, Eva" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
923 results on '"Kimby, Eva"'

Search Results

1. Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma

2. Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials

3. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

6. Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma.

8. Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials

9. Proliferative History Is a Novel Driver of Clinical Outcome in Splenic Marginal Zone Lymphoma

11. Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

15. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

17. Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia

20. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

21. Figure S1-S8 from TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma

22. Supplementary Tables S1-S2 from TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma

23. Data from TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma

24. Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment

25. Supplementary Materials and Methods from T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab

26. Lack of reproducibility of histopathological features in MYC ‐rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium

27. Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden

28. Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients : A National Population-based Study in Sweden

29. Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia

30. Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria

31. Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

32. Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial

33. Multi-Omics Profiling of Longitudinal Samples Reveals Early Genomic Changes in Follicular Lymphoma

40. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

41. Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

42. Survival by first-line treatment type and timing of progression among follicular lymphoma patients: A national population-based study in Sweden

43. Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-Waldenstrom macroglobulinemia type : A Swedish lymphoma registry study

44. Health-related quality of life and chronic fatigue in long-term survivors of indolent lymphoma – a comparison with normative data.

48. Diversity of Intratumoral Regulatory T Cells in Non-Hodgkin Lymphoma

Catalog

Books, media, physical & digital resources